Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

63.10
Delayed Data
As of Feb 05
 -1.12 / -1.74%
Today’s Change
35.78
Today|||52-Week Range
121.95
-17.83%
Year-to-Date

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Pacira Pharmaceuticals Inc have a median target of 89.00, with a high estimate of 123.00 and a low estimate of 74.00. The median estimate represents a +41.05% increase from the last price of 63.10.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Buy stock in Pacira Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.05
Sales
$68.4M
Reporting Date
Feb 23

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -37.50%
 
 
 
 
 
 
Growthannually 204.81%
 
 
 
 
 
 

Sales

Growthquarterly 9.94%
 
 
 
 
 
 
Growthannually 25.45%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.